Atlantic Genpar (Lux) Scsp General's Net Worth

$0

Estimate Recalculated Nov 11, 2024 07:52AM EST

Who is Atlantic Genpar (Lux) Scsp General

Atlantic Genpar (Lux) Scsp General does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CinCor Pharma, Inc., Centessa Pharmaceuticals plc, ALKAMI TECHNOLOGY, INC., Clear Secure, Inc., HireRight Holdings Corp, and Mobileye Global Inc..

SEC CIK

Atlantic Genpar (Lux) Scsp General's CIK is 0001857517

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CinCor Pharma, Inc.

Investor
Updated Aug 15, 2022
Form 4
2.01%
83.00K
$30.00
$2.49M
Aug 15, 2022
4.21M
Purchase
Aug 11
Form 4
-38.62%
-4.12M
$16.00
$27.20M
Jan 13, 2022
6.55M
Buy-Options
Jan 11
Form 3
Jan 06, 2022
Showing 3 results

ALKAMI TECHNOLOGY, INC.

Investor
Updated Nov 08, 2024
Form 4
-16.07%
-2.50M
$37.50
-$93.75M
Nov 08, 2024
13.06M
Sale
Nov 08
Form 4
-9.68%
-1.67M
$31.17
-$51.95M
Aug 12, 2024
15.56M
Sale
Aug 12
Form 4
0.04%
6.85K
May 17, 2024
17.22M
Grant
May 15
Form 4
-8.24%
-1.54M
$26.53
-$40.93M
May 09, 2024
17.19M
Sale
May 07
Form 4/A
Apr 21, 2021
56.19M
Options
Apr 16
Form 3/A
Apr 21, 2021
Form 4
50.24%
18.79M
$5.21
$131.60M
Apr 20, 2021
56.19M
Options
Apr 16
Showing 7 results

Clear Secure, Inc.

Investor
Updated Jan 30, 2023
Form 4
-18.78%
-1.80M
$29.00
-$52.24M
Jan 30, 2023
7.79M
Sale
ScheduledJan 26
Form 4
-15.80%
-1.80M
$29.10
-$52.38M
Jan 20, 2023
9.59M
Sale
ScheduledJan 18
Form 4
-25.01%
-3.80M
$31.65
-$120.27M
May 19, 2022
11.39M
Sale
May 17
Form 4
3.34%
300.00K
$31.00
$9.30M
Jul 07, 2021
9.29M
Grant
Jul 02
Showing 4 results

HireRight Holdings Corp

Investor
Updated Jun 28, 2024
Form 4
-99.81%
-32.17M
$14.35
-$870.93K
Jun 28, 2024
60.69K
Disposition
Jun 28
Form 4
0.15%
49.50K
May 30, 2023
32.18M
Options
May 25
Form 4
0.11%
35.87K
$12.34
$442.61K
Dec 12, 2022
32.11M
Purchase
ScheduledDec 08
Form 4
0.64%
408.10K
$12.91
$5.19M
Dec 07, 2022
63.84M
Purchase
ScheduledDec 05 - Dec 07
Form 4
0.44%
279.11K
$12.63
$3.49M
Dec 02, 2022
63.10M
Purchase
ScheduledNov 30 - Dec 02
Form 4
1.92%
591.82K
$11.85
$7.01M
Nov 29, 2022
31.39M
Purchase
Nov 25 - Nov 29
Form 4
1.72%
520.11K
$10.62
$5.53M
Nov 23, 2022
30.79M
Purchase
Nov 21 - Nov 23
Form 4
1.87%
554.99K
$9.64
$5.35M
Nov 18, 2022
30.27M
Purchase
Nov 16 - Nov 18
Showing 8 results

Mobileye Global Inc.

Investor
Updated Nov 07, 2022
Form 3
Nov 07, 2022
4.76M
Showing 1 results

Centessa Pharmaceuticals plc

Investor
Updated Jun 26, 2023
Form 4
48.00K
Jun 26, 2023
48.00K
Grant
Jun 22
Form 4
48.00K
Jul 05, 2022
48.00K
Grant
Jun 30
Form 4
18.33%
1.50M
$20.00
$30.00M
Jun 03, 2021
9.68M
Purchase
Jun 02
Form 3
May 27, 2021
Showing 4 results